- Home
- VCYT vs NAD Comparison
VCYT vs NAD Comparison
Compare VCYT & NAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VCYT | NAD |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.9B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | VCYT | NAD |
|---|---|---|
| Price | $32.95 | $12.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $45.13 | N/A |
| AVG Volume (30 Days) | ★ 802.9K | 644.8K |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.35% |
| EPS Growth | ★ 164.52 | N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.33 | N/A |
| Revenue Next Year | $12.53 | N/A |
| P/E Ratio | $41.38 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.61 | $10.40 |
| 52 Week High | $50.71 | $12.31 |
Technical Indicators
Market Signals| Indicator | VCYT | NAD |
|---|---|---|
| Relative Strength Index (RSI) | 34.55 | 45.60 |
| Support Level | $32.51 | $12.00 |
| Resistance Level | $32.79 | $12.14 |
| Average True Range (ATR) | 1.45 | 0.08 |
| MACD | -0.16 | -0.02 |
| Stochastic Oscillator | 0.42 | 41.89 |
Price Performance
Historical ComparisonAbout VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
About NAD Nuveen Quality Municipal Income Fund
Nuveen Quality Municipal Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide current income exempted from regular federal income tax by investing in tax-exempt municipal securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.